FindMyKOL
Clinical trialNCT02773602UnknownPhase 4Interventional

Dexamethasone or Clonidine as Adjuncts to Ropivacaine for Caudal Analgesia on Analgesia Duration in Children

NCT02773602 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. As of 18 Nov 2026, it has a status the registry marks as unknown. It studies Clonidine, Dexamethasone and Normal Saline in Postoperative Pain. The registry lists an enrollment of 155 participants at 1 site in 1 country. The registry lists a start date of 31 May 2011 and a primary completion date of 31 Dec 2016.

SponsorThe University of Texas Health Science Center, HoustonEnrollment155Postoperative Pain
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02773602
FieldValue
Registry IDNCT02773602
StatusUnknown
PhasePhase 4
Study typeInterventional trial
Lead sponsorThe University of Texas Health Science Center, Houston
Enrollment155
Registered sites1
Countries1
ConditionsPostoperative Pain
DrugsClonidine, Dexamethasone and Normal Saline
Start31 May 2011
Primary completion31 Dec 2016
Study completion31 Dec 2017
Last update posted16 May 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Comparing the duration of pain relief from caudal analgesia when adjuncts like dexamethasone, clonidine, or saline (salt water) are added to ropivacaine.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Samia N Khalil, (M.B; B.CH)

    The University of Texas Health Science Center, Houston

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site, 1 recruiting
  • Memorial Hermann Hospital

    Houston

    Samia N Khalil, (M.B; B.CH)
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 site, 1 recruitingTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT02773602

Each answer restates registry values shown on this page.

What is NCT02773602?

NCT02773602 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. It studies Clonidine, Dexamethasone and Normal Saline in Postoperative Pain.

Who leads NCT02773602?

The registry names Samia N Khalil, (M.B; B.CH) (principal investigator, The University of Texas Health Science Center, Houston) as the overall official.

Where does NCT02773602 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT02773602 study?

The registered drug and biological interventions are Clonidine, Dexamethasone and Normal Saline.

When is NCT02773602 expected to complete?

The registry lists a primary completion date of 31 Dec 2016 and a study completion date of 31 Dec 2017. The sponsor last updated the record on 16 May 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.